A study on fibrolamellar hepatocellular carcinoma demonstrated that IGF2BP1 upregulation is associated with the downregulation of the p53 tumor-suppressor pathway (36). Here, IGF2BP1 is linked to fibrolamellar hepatocellular carcinoma.